Search Results - "Garrido, Federico"
-
1
HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy
Published in Cellular & molecular immunology (01-03-2021)“…T cell-mediated immune therapies have emerged as a promising treatment modality in different malignancies including colorectal cancer (CRC). However, only a…”
Get full text
Journal Article -
2
The urgent need to recover MHC class I in cancers for effective immunotherapy
Published in Current opinion in immunology (01-04-2016)“…Highlights • Tumor immune escape compromises the efficacy of cancer immunotherapy. • Loss of MHC class I expression is a frequent event in cancer cells. •…”
Get full text
Journal Article -
3
“Hard” and “soft” lesions underlying the HLA class I alterations in cancer cells: Implications for immunotherapy
Published in International journal of cancer (15-07-2010)“…The ability of cancer cells to escape from the natural or immunotherapy‐induced antitumor immune response is often associated with alterations in the tumor…”
Get full text
Journal Article -
4
MHC heterogeneity and response of metastases to immunotherapy
Published in Cancer and metastasis reviews (01-06-2021)“…In recent years, immunotherapy has proven to be an effective treatment against cancer. Cytotoxic T lymphocytes perform an important role in this anti-tumor…”
Get full text
Journal Article -
5
Metastases in immune-mediated dormancy: a new opportunity for targeting cancer
Published in Cancer research (Chicago, Ill.) (01-12-2014)“…The aim of any anticancer treatment is to avoid, control, or eliminate disseminated tumor cells. Clinical and experimental evidence has revealed that…”
Get full text
Journal Article -
6
Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes
Published in Cancer Immunology, Immunotherapy (01-09-2012)“…Classical MHC molecules present processed peptides from endogenous protein antigens on the cell surface, which allows CD8 + cytotoxic T lymphocytes (CTLs) to…”
Get full text
Journal Article -
7
Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors
Published in Cancer research (Chicago, Ill.) (15-06-2013)“…Cancer immunosurveillance relies on effector/memory tumor-infiltrating CD8(+) T cells with a T-helper cell 1 (TH1) profile. Evidence for a natural killer (NK)…”
Get full text
Journal Article -
8
Scientific production in biodiversity: the gender gap continues in Brazilian universities
Published in Anais da Academia Brasileira de Ciências (01-01-2023)“…Scientometrics enables us to comprehend the interests and trends in scientific knowledge production and dissemination. In this study, we evaluate the effects…”
Get full text
Journal Article -
9
Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset
Published in Frontiers in immunology (26-11-2020)“…The severity of SARS-CoV-2 infection has been related to uncontrolled inflammatory innate responses and impaired adaptive immune responses mostly due to…”
Get full text
Journal Article -
10
‘No State, No Masters’: Café Lavandería in Tokyo, Music, and Anticapitalism in a Cultural Environment
Published in Arts (Basel) (01-08-2024)“…This paper is part of a series of research that these authors are conducting to study the linguistic landscape of the Tokyo megacity. In this instance, our…”
Get full text
Journal Article -
11
Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes
Published in International journal of molecular sciences (06-07-2021)“…Cancer eradication and clinical outcome of immunotherapy depend on tumor cell immunogenicity, including HLA class I (HLA-I) and PD-L1 expression on malignant…”
Get full text
Journal Article -
12
MHC class I antigens, immune surveillance, and tumor immune escape
Published in Journal of cellular physiology (01-06-2003)“…Oncogenic transformation in human and experimental animals is not necessarily followed by the appearance of a tumor mass. The immune system of the host can…”
Get full text
Journal Article -
13
Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach
Published in International journal of molecular sciences (15-06-2015)“…Colorectal cancer is a heterogeneous disease that manifests through diverse clinical scenarios. During many years, our knowledge about the variability of…”
Get full text
Journal Article Book Review -
14
Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients
Published in Journal of microbiology, immunology and infection (01-06-2022)“…Human leukocyte antigen (HLA) plays an important role in immune responses to infections, especially in the development of acquired immunity. Given the high…”
Get full text
Journal Article -
15
The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture
Published in Vaccines (Basel) (27-02-2017)“…Tumor immune escape is associated with the loss of tumor HLA class I (HLA-I) expression commonly found in malignant cells. Accumulating evidence suggests that…”
Get full text
Journal Article -
16
MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy
Published in Frontiers in immunology (29-01-2018)“…An individual tumor can present intratumoral phenotypic heterogeneity, containing tumor cells with different phenotypes that do not present irreversible…”
Get full text
Journal Article -
17
Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patients
Published in Oncotarget (11-12-2018)“…The Revised International Prognostic Score and some somatic mutations in myelodysplastic syndrome (MDS) are independently associated with transformation to…”
Get full text
Journal Article -
18
Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab
Published in Frontiers in pharmacology (06-10-2017)“…Defining how epidermal growth factor receptor (EGFR)-targeting therapies influence the immune response is essential to increase their clinical efficacy. A…”
Get full text
Journal Article -
19
-
20
A new extract of the plant Calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation
Published in BMC cancer (05-05-2006)“…Phytopharmacological studies of different Calendula extracts have shown anti-inflammatory, anti-viral and anti-genotoxic properties of therapeutic interest. In…”
Get full text
Journal Article